Search - tctmd.com

Displaying 101 - 120 of 478

Sort: Relevancy | Date

Presentation TCT 2017

Debate: Based on EXCEL and NOBLE, PCI Should Become Class IA for Left Main Revascularization If Technically Feasible, at Least in Intermediate and Low SYNTAX Score Patients!

Presenter: Evald H. Christiansen, Erick Schampaert, Marco V. Wainstein

October 31, 2017

Presentation TCT 2017

Mirage: Imaging and Clinical Outcomes With a Circular PLLA Microfiber-Derived BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2017

Presentation TCT 2017

Left Main Case(s) #7: Rationale and Feasibility of Bioresorbable Scaffolds

Presenter: Kenneth Chin, Nicholas J. Lembo, Bernardo Cortese

October 31, 2017

Presentation TCT 2017

The Thin-Strut PLLA-Based MeRes100

Presenter: Ron Waksman, Robert-Jan van Geuns, Ashok Seth

October 31, 2017

Presentation TCT 2017

The Sirolimus-Eluting PLLA-Based Neovas Scaffold: Extended Results From the Randomized Trial

Presenter: Bernard R. Chevalier, Corrado Tamburino, Kai Xu

October 31, 2017

Presentation TCT 2017

Magmaris: Clinical and Imaging Results With Drug-Eluting Magnesium-Based Scaffolds

Presenter: Bernard R. Chevalier, Corrado Tamburino, Ron Waksman

October 31, 2017

Presentation TCT 2017

The Role of Left Main PCI After EXCEL and NOBLE

Presenter: Alaide Chieffo, Jonathan M. Hill, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Fortitude, Aptitude, and Magnitude: Progressively Thin-Strut BRS Based on Ultra-High Molecular Weight Amorphous PLLA

Presenter: Bernard R. Chevalier, Corrado Tamburino, Juan F. Granada

October 31, 2017

Presentation TCT 2017

Fantom: A Radio-Opaque Stent-Like BRS With Improved Expansion Characteristics

Presenter: Bernard R. Chevalier, Corrado Tamburino, James B. Hermiller Jr.

October 31, 2017

Presentation TCT 2017

Desolve Nx, Cx, and Amity: A Family of Progressively Thinner-Strut PLLA-Based BRS With Novel Properties

Presenter: Bernard R. Chevalier, Corrado Tamburino, Stefan Verheye

October 31, 2017

Presentation TCT 2017

Do Some, All, or None of the Outcomes With the First Generation Absorb Scaffold Imply a Class Effect for All BRS? Educated Insights

Presenter: Bernard R. Chevalier, Corrado Tamburino, Yoshinobu Onuma

October 31, 2017

Presentation TCT 2017

Has DK Crush Emerged As the New Standard for Two-Stent Left Main PCI? Results From the DKCRUSH-III and DKCRUSH-V Trials

Presenter: David Hildick-Smith, Jeffrey W. Moses, Zhen Ge

October 31, 2017

Presentation TCT 2017

Is There a Role for Dedicated Stents for the Left Main Bifurcation? Rationale and Device Landscape (With Case Examples)

Presenter: David Hildick-Smith, Jeffrey W. Moses, Carlo Briguori

October 31, 2017

Presentation TCT 2017

Debate: With Improved Technology and Optimal Technique ABSORB Will Become a Widely Used Device

Presenter: Stephen G. Ellis, Takeshi Kimura, Hiram G. Bezerra

October 31, 2017

Presentation TCT 2017

Coronary Stents for Left Main PCI: Considerations on Design and Selection, With Bench Examples

Presenter: David Hildick-Smith, Jeffrey W. Moses, Nicolas Foin

October 31, 2017

Presentation TCT 2017

Debate: ABSORB Is Likely Finished - The Limitation of the Technology Can Not Be Overcome

Presenter: Stephen G. Ellis, Takeshi Kimura, Robert A. Byrne

October 31, 2017

Presentation TCT 2017

Firehawk Sirolimus-Eluting Stent: Device Specifications and Clinical Program Update

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Qi Zhang

October 31, 2017

Presentation TCT 2017

The Potential For BRS: What Weve Learned From Pushing The Envelope

Presenter: Stephen G. Ellis, Takeshi Kimura, Corrado Tamburino

October 31, 2017

Presentation TCT 2017

Registry Update: ABSORB SCAAR

Presenter: Stephen G. Ellis, Takeshi Kimura, Stefan K. James

October 31, 2017

Presentation TCT 2017

Buma Stent: Device Specifications, Clinical Trial Results, and Global Development

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Kefei Dou

October 31, 2017

Advertisement

Debate: Based on EXCEL and NOBLE, PCI Should Become Class IA for Left Main Revascularization If Technically Feasible, at Least in Intermediate and Low SYNTAX Score Patients!

Mirage: Imaging and Clinical Outcomes With a Circular PLLA Microfiber-Derived BRS

Left Main Case(s) #7: Rationale and Feasibility of Bioresorbable Scaffolds

The Thin-Strut PLLA-Based MeRes100

The Sirolimus-Eluting PLLA-Based Neovas Scaffold: Extended Results From the Randomized Trial

Magmaris: Clinical and Imaging Results With Drug-Eluting Magnesium-Based Scaffolds

The Role of Left Main PCI After EXCEL and NOBLE

Fortitude, Aptitude, and Magnitude: Progressively Thin-Strut BRS Based on Ultra-High Molecular Weight Amorphous PLLA

Fantom: A Radio-Opaque Stent-Like BRS With Improved Expansion Characteristics

Desolve Nx, Cx, and Amity: A Family of Progressively Thinner-Strut PLLA-Based BRS With Novel Properties

Do Some, All, or None of the Outcomes With the First Generation Absorb Scaffold Imply a Class Effect for All BRS? Educated Insights

Has DK Crush Emerged As the New Standard for Two-Stent Left Main PCI? Results From the DKCRUSH-III and DKCRUSH-V Trials

Is There a Role for Dedicated Stents for the Left Main Bifurcation? Rationale and Device Landscape (With Case Examples)

Debate: With Improved Technology and Optimal Technique ABSORB Will Become a Widely Used Device

Coronary Stents for Left Main PCI: Considerations on Design and Selection, With Bench Examples

Debate: ABSORB Is Likely Finished - The Limitation of the Technology Can Not Be Overcome

Firehawk Sirolimus-Eluting Stent: Device Specifications and Clinical Program Update

The Potential For BRS: What Weve Learned From Pushing The Envelope

Registry Update: ABSORB SCAAR

Buma Stent: Device Specifications, Clinical Trial Results, and Global Development

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content